New Drug Screening Technique Solutions Why Alzheimer’s Drugs Fail, New Targets Suggestions

New Drug Screening Technique Solutions Why Alzheimer’s Drugs Fail, New Targets Suggestions

Researchers led by the University of California San Diego created a new technique to test medications for the treatment of Alzheimer’s disease by examining disease…
A New Study Reveals Genes Can Predict Arthritis Treatment Response, Opening the Door to Future Drug Development

A New Study Reveals Genes Can Predict Arthritis Treatment Response, Opening the Door to Future Drug Development

The effectiveness of particular pharmacological therapies for patients with rheumatoid arthritis (RA) can be strongly impacted by the molecular profiling of the diseased joint tissue,…
Promising MND Drug Slows Disease Progression and Has Physical Benefits for Patients

Promising MND Drug Slows Disease Progression and Has Physical Benefits for Patients

After a Phase 3 clinical trial revealed significant physical gains for patients after 12 months, researchers believe a new genetically tailored therapy for motor neurone…
‘Last Resort’ Antibiotic’s Common Drug-Resistant Superbug Develops Rapid Resistance

‘Last Resort’ Antibiotic’s Common Drug-Resistant Superbug Develops Rapid Resistance

Colistin is a “last resort” antibiotic for patients with infections that have become multi-drug resistant. A study that was just released in Cell Reports describes…
A Limited Use of Current Cancer Therapy Demonstrates Significant Activity Against Other Cancers

A Limited Use of Current Cancer Therapy Demonstrates Significant Activity Against Other Cancers

Under specific circumstances, a medication that targets IDH1 mutations in some malignancies also seems to block the enzyme’s wild-type form. This characteristic explains why a…
Study Discovers That COVID-19 Rebound Following Paxlovid Use Is Likely the Result of Insufficient Drug Exposure

Study Discovers That COVID-19 Rebound Following Paxlovid Use Is Likely the Result of Insufficient Drug Exposure

The most effective oral treatment for avoiding severe COVID-19 instances in high-risk persons is paxlovid. A health advisory on this alleged “COVID-19 rebound” was released…
In a Mouse Model, a New Personalized Treatment Idea to Prevent Colitis

In a Mouse Model, a New Personalized Treatment Idea to Prevent Colitis

According to a recent study, researchers at Georgia State University’s Institute for Biomedical Sciences have created a novel oral medication for ulcerative colitis that aims…
AI Examines Neuronal Changes to Determine whether Drugs Work for Patients with Neurodegenerative Disease

AI Examines Neuronal Changes to Determine whether Drugs Work for Patients with Neurodegenerative Disease

An artificial intelligence for assessing cell pictures that employs machine learning to anticipate the therapeutic effect of medications has been developed by a research team…
Differential Responses of Cancer Cells to Drug-Delivery Nanoparticles

Differential Responses of Cancer Cells to Drug-Delivery Nanoparticles

Cancer treatments can be delivered to tumors in high dosages using nanoparticles while avoiding the negative side effects associated with chemotherapy. Only a small number…
A Cancer Drug that has been Shelved Could Receive a Second Chance with Personalized Medicine

A Cancer Drug that has been Shelved Could Receive a Second Chance with Personalized Medicine

Triplatin is effective against triple negative breast cancer, the most aggressive type of breast cancer with limited targeted medicines, according to a study by Virginia…
Use of Anti-Epileptic Drugs and Non-Benzo Sleep Aids at the Same Time Increased Drug Overdose Deaths Due to Gabapentinoids

Use of Anti-Epileptic Drugs and Non-Benzo Sleep Aids at the Same Time Increased Drug Overdose Deaths Due to Gabapentinoids

Researchers at Columbia University Mailman School of Public Health sought to close the knowledge gap regarding the percentage of overdose deaths involving non-benzo sleeping/z-drugs and…
Patients with Newly Diagnosed Mantle Cell Lymphoma Have Improved Progression-Free Survival When Taking Ibrutinib and Chemo-Immunotherapy

Patients with Newly Diagnosed Mantle Cell Lymphoma Have Improved Progression-Free Survival When Taking Ibrutinib and Chemo-Immunotherapy

For previously untreated mantle cell lymphoma (MCL) in patients 65 and older, combination chemotherapy with the Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib demonstrated improved progression-free…
Load More